Skip to main content
. 2020 Jul 30;2020:3267971. doi: 10.1155/2020/3267971

Table 2.

Characteristics of included studies.

Study ID Sample (E/C) Age (years) Sex (M/F) Diagnosis standard Hypertension classification (E/C) Frequency Experimental groups Control groups Duration Outcome indicators Dropout (E/C)
Chen [45] 30/30 66.3 ± 5.8 NR NR EH 44 min/day, 5 days/week Qigong (Mawangdui Daoyinshu) No intervention 6 months SBP, DBP, NO, ET-1 NR
Chen [46] 30/30 E: 69.23 ± 3.72
C: 70.06 ± 3.51
E: 13/14
C: 16/12
GPTHC (2005 edition) EH, stage I (60) 30 min/day, 5 days/week Qigong (Baduanjin) + antihypertensive drug Antihypertensive drug (amlodipine besylate 5 mg qd or telmisartan 80 mg qd) 3 months SBP, DBP, NO, ET-1 3/2
Chen [47] 20/20 E: 64.3
C: 60.7
E: 9/11
C: 13/7
GPTHC (2004 edition) EH, stage II (26), stage III (14) 40 min/day, 7 days/week Chen-style Tai Chi + antihypertensive drug Antihypertensive drug (nifedipine sustained-release tablets, EH of stage II: 25 mg bid; EH of stage III: 50 mg bid) 2.5 months SBP, DBP, NO 0/0
Fu [48] 30/30 E: 57.93 ± 6.63
C: 59.53 ± 7.46
E: 20/10
C: 19/11
GPTHC (2010 edition) EH, stage I (24/21), stage II (6/9) 40 min/day, 6 days/week Qigong (self-compiled) + antihypertensive drug Antihypertensive drug (CCB, ACEI, ARB, DAD.
NR specific drug and dosage)
3 months SBP, DBP, NO, ET-1 NR
Jin et al. [49] 27/27 56.9 ± 5.7 11/43 GPTHC (2010 edition) EH, stage I (54) 40 min/day, 7 days/week 24-movement Yang-style Tai Chi Antihypertensive drug (amlodipine 2.5 mg qd) 1.5 months SBP, DBP, NO, ET-1 0/0
Liu [50] 30/30 E: 56.8 ± 6.78
C: 56.33 ± 7.16
E: 16/14
C: 19/11
GPTHC (2015 edition) EH, stage I (19/21), stage II (11/9) 40 min/day, 5 days/week 24-movement Yang-style Tai Chi + antihypertensive drug Antihypertensive drug (amlodipine besylate 5 mg qd) 3 months NO, ET-1 NR
Xiao et al. [51] 24/24 65.6 ± 7.8 NR NR EH 40 min/day, 5 days/week Qigong (Baduanjin) No intervention 6 months SBP, DBP, NO, ET-1 NR
Xiao [52] 42/42 E:60.2 ± 4.6
C: 60.5 ± 4.9
E: 24/18
C: 22/20
GPTHC (2010 edition) EH 60 min/day, 5 days/week 8-style Tai Chi + aerobic exercise Aerobic exercise (jog and walk fast) 3 months SBP, DBP, NO, ET-1 NR
Xie et al. [53] 25/25 60–70 E: 11/14
C: 14/11
GPTHC (2005 edition) EH, stage I (20), stage II (30) 60 min/day, 5 days/week 24-movement Yang-style Tai Chi No intervention 3 months SBP, DBP, NO NR

E: experimental group, C: control group, M: male, F: female, EH: essential hypertension; NR: not reported; GPTHC: Guidelines for Prevention and Treatment of Hypertension in China, SBP: systolic blood pressure, DBP: diastolic blood pressure, NO: nitric oxide, ET-1: endothelin-1, CCB: calcium channel blockers, ACEI: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker, DAD: diuretic antihypertensive drug, qd: quaque die/once day, bid: bis in die/twice day. Diagnosis standard: GPTHC (2004 edition): phase II (160 mmHg ≤ SBP ≤ 179 mmHg and/or 100 mmHg ≤ DBP ≤ 109 mmHg), phase III (SBP ≥ 180 mmHg and/or DBP ≥ 110 mmHg). GPTHC (2005 edition): phase I (140 mmHg ≤ SBP ≤ 159 mmHg, and/or 90 mmHg ≤ DBP ≤ 99 mmHg), phase II (160 mmHg≤ SBP < 180 mmHg and/or 100 mmHg ≤ DBP < 110 mmHg). GPTHC (2010 edition): phase I (140 mmHg ≤ SBP ≤ 159 mmHg and/or 90 mmHg ≤ DBP ≤ 99 mmHg), phase II (160 mmHg ≤ SBP < 179 mmHg and/or 100 mmHg ≤ DBP < 109 mmHg). GPTHC (2015 edition): phase I (140 mmHg ≤ SBP ≤ 159 mmHg and/or 90 mmHg ≤ DBP ≤ 99 mmHg), phase II (160 mmHg ≤ SBP ≤ 179 mmHg and/or 100 mmHg ≤ DBP ≤ 109 mmHg). Additional description: the 8-style Tai Chi is also called Yi-duan Quan and adopts the eight main and basic movements of Yang-style Tai Chi. There are 10 movements in the 8-style Tai Chi (including starting and ending). The exercise moves from slow to slightly fast and then from slightly fast to slowly end. Chen-style Tai Chi is characterized by the combination of Yin and Yang and the combination of hardness and softness. This exercise has slow/soft movements similar to the Yang-style and fast/hard movements similar to aerobic exercises.